Knott David M Jr

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$168.0M
Q ending 2026-03-31
Prior quarter
$215.9M
Q ending 2025-12-31
Change
-22.2% QoQ · -20.7% YoY
Positions
85
reported holdings

Largest positions

All 85 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Alphabet Inc-Cl CGOOGShares$26.2M91K
Apollo Global Management, Inc.APOShares$25.1M225K
Syndax Pharmaceutical, Inc.SNDXShares$9.9M422K
Bridgebio Pharma, Inc.BBIOShares$6.7M90K
Protagonist Therapeutics, IncPTGXShares$6.6M63K
Xeris Biopharma Holdings, Inc.XERSShares$6.1M1.1M
Jpmorgan Chase & Co.JPMShares$5.7M19K
Iovance Biotherapeutics, Inc.IOVAShares$5.6M1.6M
Lpl Financial Holdings Inc.Shares$5.0M17K
Janus Henderson Aaa Clo EtfJAAAShares$4.7M94K
Alkermes PlcShares$4.2M120K
Travere Therapeutics, Inc.TVTXShares$4.2M141K
Cogent Biosciences Inc.COGTShares$4.0M104K
Viridian Therapeutics, Inc.VRDNShares$3.5M181K
Agios Pharmaceutical, Inc.AGIOShares$3.1M93K
Relmada Therapeutics, Inc.RLMDShares$3.1M439K
Tg Therapeutics, Inc.TGTXShares$3.0M90K
Catalyst Pharmaceuticals, Inc.Shares$3.0M120K
Arcellx IncShares$2.2M19K
Spdr S&P Biotech EtfXBIShares$1.9M15K
Alliancebernstein Holding L.P.ABShares$1.8M48K
Arcus Biosciences, Inc.RCUSShares$1.8M81K
Docgo, Inc.DCGOShares$1.7M2.7M
Cybin IncHELPShares$1.7M350K
Cytokinetics, IncorporatedCYTKShares$1.6M24K
Centessa Pharmaceuticals Plc260Shares$1.5M39K
Atricure, Inc.ATRCShares$1.5M51K
Ardelyx, Inc.ARDXShares$1.2M207K
The Panagram Bbb-B Clo EtfCLOZShares$1.2M48K
Johnson & JohnsonJNJShares$1.2M5K
Rezolute, Inc.RZLTShares$1.1M370K
Orchestra Biomed Holdings, Inc.OBIOShares$1.1M254K
Madrigal Pharmaaceuticals, Inc.MDGLShares$1.0M2K
Vera Therapeutics, Inc.VERAShares$1.0M26K
Connect Biopharma Holdings LimitedShares$1.0M388K
Ishares Biotechnology EtfIBBShares$929K6K
Pfizer Inc.PFEShares$908K32K
Bristol-Myers Squibb CompanyBMYShares$826K14K
Canadian Natural Resources LimitedCNQShares$819K17K
Biogen Inc.BIIBShares$733K4K
Ultragenyx Pharmaceutical Inc.RAREShares$693K33K
Apple Inc.AAPLShares$633K2K
Microsoft CorporationMSFTShares$592K2K
Verastem Inc.VSTMShares$551K104K
Adma Biologics, Inc.ADMAShares$542K60K
International Business MachinesIBMShares$519K2K
Biohaven Pharmaceutical Holding CoShares$514K61K
Pelthos Therapeutics, Inc.PTHSShares$443K21K
Kura Oncology, Inc.KURAShares$429K53K
Evolus, Inc.Shares$408K99K
Cullinan Therapeutics, Inc.CGEMShares$344K24K
Solid Bioscience Inc.SLDBShares$339K47K
Lenz Therapeutics, Inc.LENZShares$309K34K
Wave Life Science Ltd.Shares$290K40K
Rain Enhancement Technologies HoldRAINShares$258K102K
Kimberly-Clark CorporationKMBShares$232K2K
Nvidia CorpNVDAShares$223K1K
Ryman Hospitality Properties, Inc.RHPShares$221K2K
Broadcom, Inc.AVGOShares$220K710
Mondelez International, Inc.MDLZShares$173K3K
Dupont De Nemours, Inc.DDUSDShares$173K4K
Jasper Therapeutics, Inc.JSPRShares$141K161K
Invivyd, Inc.IVVDShares$130K100K
Corteva, Inc.CTVAShares$101K1K
Mereo Biopharm Group PlcMREOShares$99K300K
Eastern Bankshares IncEBCShares$98K5K
Quanta Services, Inc.PWRShares$97K176
Ishares Russell Mid-Cap GrowthIWPShares$89K695
Alphabet Inc Cl AShares$86K300
Legacy Housing CorporationLEGHShares$82K4K
Amazon.Com Inc.AMZNShares$62K300
United Rental, Inc.URIShares$57K78
Dow Inc.DOWShares$50K1K
Occidental Petroleum CorporationOXYShares$35K663
Danaher CorporationDHRShares$34K180
Brightstar Lottery PlcShares$32K3K
Fs Kkr Capital Corp.FSICUSDShares$29K3K
Blackstone Group LpShares$24K210
Thermo Fisher Scientific, Inc.TMOShares$22K45
United Healthcare Corp.Shares$15K57
Salesforce, Inc.CRMShares$14K77
Starwood Property Trust, Inc.STWDShares$7K400
Kyndryl Holdings Inc.KDShares$6K428
Ge Healthcare Technologies IncGEHCShares$4K50
Wabtec CorporationWABShares$1K6

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.